# Helen McBreen

> Helen McBreen is a seed investor at Atlantic Bridge (Dublin) backing Sports and Medical. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Atlantic Bridge](https://shizune.co/investors/profile/atlantic-bridge)
- Location: Dublin, Ireland
- Total investments: 5
- Last investment: Mar 2023
- Lead investor: 60%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/mcbreenhelen
- X (Twitter): http://twitter.com/hmcbrn
- Website: https://x.com/hmcbrn

Helen McBreen is a seed investor at Atlantic Bridge in Dublin focused on Sports and Medical. Helen McBreen is based out of Dublin and is the Partner of Atlantic Bridge. Helen previously worked at NDRC as a Commercial Development Leader. Helen McBreen attended the University College Dublin. Helen McBreen has received Top 100 Women in STEM award.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Sports | 1 | 20% |
| Medical | 1 | 20% |
| Big Data | 1 | 20% |
| Hospital | 1 | 20% |
| Health Care | 1 | 20% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 40% |
| Funding Round | 2 | 40% |
| Series A | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Output Sports | Output Sports operates as a sports tech start-up. We are revolutionizing the way athletic staff optimize sports performance. Using advanced signal processing and machine learning techniques we have developed an end-to-end solution that can test multiple components of athletic performance and track training programmes with a single wearable sensor. | $4.8M | Seed | Jan 30, 2025 |  |
| Bluedrop Medical | It has been estimated that up to 25% of diabetics will develop a foot ulcer at some point in their life. One of the main causes is peripheral neuropathy, which results in a patient losing sensation in their feet. Of the millions who develop ulcers every year, hundreds of thousands will require amputation due to infection. In 2014, Ireland recordedan increase in the number of amputations as a result of diabetes, with 8 limbs being lost every week. | $11.5M |  | Mar 31, 2023 |  |
| Bluedrop Medical | It has been estimated that up to 25% of diabetics will develop a foot ulcer at some point in their life. One of the main causes is peripheral neuropathy, which results in a patient losing sensation in their feet. Of the millions who develop ulcers every year, hundreds of thousands will require amputation due to infection. In 2014, Ireland recordedan increase in the number of amputations as a result of diabetes, with 8 limbs being lost every week. | $11.4M | Seed | Mar 31, 2023 |  |
| AYLIEN | Aylien is an artificial intelligence startup that focuses on creating technologies that help machines understand human languages better. The firm provides Text Analysis and News API's that allow users to make sense of human-generated content at scale. AYLIEN also provides a range of content analysis solutions to developers, data scientists,marketers and academics. Their core offerings include packages of information retrieval, machine learning, natural language processing and image recognition APIs. | $5.5M | Series A | Dec 20, 2019 |  |
| AYLIEN | Aylien is an artificial intelligence startup that focuses on creating technologies that help machines understand human languages better. The firm provides Text Analysis and News API's that allow users to make sense of human-generated content at scale. AYLIEN also provides a range of content analysis solutions to developers, data scientists,marketers and academics. Their core offerings include packages of information retrieval, machine learning, natural language processing and image recognition APIs. | $2.5M |  | Aug 21, 2017 |  |

5 of 5 investments shown.

## Co-investors
- [Elkstone Capital Partners](https://shizune.co/investors/profile/elkstone-capital-partners) — VC Fund, 3 deals together
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund, 3 deals together
- [Ascentifi](https://shizune.co/investors/profile/ascentifi) — VC Fund, 2 deals together
- [Furthr VC](https://shizune.co/investors/profile/dbic-ventures) — VC Fund, 2 deals together
- [European Innovation Council](https://shizune.co/investors/profile/european-innovation-council) — VC Fund, 2 deals together
- [HBAN Medtech Syndicate](https://shizune.co/investors/profile/hban-medtech-syndicate) — VC Fund, 2 deals together

## About Atlantic Bridge

VC Fund · Dublin, Ireland

Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.

5 contacts available at Atlantic Bridge.

| Name | Title | Profile |
| --- | --- | --- |
| Brian Long | Managing Partner | https://shizune.co/investors/profile/brian-long-4 |
| Gerry Maguire | Co-Founder and General Partner | https://shizune.co/investors/profile/gerry-maguire |
| Helen McBreen | Partner | https://shizune.co/investors/profile/helen-mcbreen |
| Kevin Dillon | Managing Partner & Co-Founder | https://shizune.co/investors/profile/kevin-dillon |
| Chris Horn | Venture Partner | https://shizune.co/investors/profile/chris-horn |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Helen McBreen invest in?

Helen McBreen invests primarily in Sports, Medical and Big Data startups, most often at Seed and Funding Round stage. Most of the 5 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Helen McBreen last invest?

The most recent investment recorded for Helen McBreen closed in Mar 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co